Nautilus Biotechnology, Inc. (NAUT) stock
NAUTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$2.36+0.26 (+12.38%)
Close on Nov 17, 2026Market cap $300.60MP/E –Yield –
Nautilus Biotechnology EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Nautilus Biotechnology
Nautilus Biotechnology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?